IL108149D0 - Component B protein, its preparation and pharmaceutical compositions containing it - Google Patents

Component B protein, its preparation and pharmaceutical compositions containing it

Info

Publication number
IL108149D0
IL108149D0 IL10814993A IL10814993A IL108149D0 IL 108149 D0 IL108149 D0 IL 108149D0 IL 10814993 A IL10814993 A IL 10814993A IL 10814993 A IL10814993 A IL 10814993A IL 108149 D0 IL108149 D0 IL 108149D0
Authority
IL
Israel
Prior art keywords
protein
preparation
component
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL10814993A
Other versions
IL108149A (en
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ITRM920919A priority Critical patent/IT1257184B/en
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL108149D0 publication Critical patent/IL108149D0/en
Publication of IL108149A publication Critical patent/IL108149A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
IL10814993A 1992-12-22 1993-12-22 Component b protein, its preparation and pharmaceutical compositions containing it IL108149A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITRM920919A IT1257184B (en) 1992-12-22 1992-12-22 Prepared to attivita 'anti-inflammatory, anticoagulant and antitumoral

Publications (2)

Publication Number Publication Date
IL108149D0 true IL108149D0 (en) 1994-04-12
IL108149A IL108149A (en) 2005-05-17

Family

ID=11401349

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10814993A IL108149A (en) 1992-12-22 1993-12-22 Component b protein, its preparation and pharmaceutical compositions containing it

Country Status (17)

Country Link
US (1) US5908827A (en)
EP (1) EP0675956B1 (en)
JP (1) JP3025014B2 (en)
AT (1) AT236976T (en)
AU (1) AU690093B2 (en)
CA (1) CA2151156A1 (en)
DE (2) DE69332861D1 (en)
DK (1) DK0675956T3 (en)
ES (1) ES2193152T3 (en)
FI (2) FI114478B (en)
IL (1) IL108149A (en)
IT (1) IT1257184B (en)
NO (1) NO315800B1 (en)
PT (1) PT675956E (en)
RU (1) RU2177480C2 (en)
WO (1) WO1994014959A1 (en)
ZA (1) ZA9309621B (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT234110T (en) * 1996-04-24 2003-03-15 Applied Research Systems Component b as a wound healing agent
AU8536698A (en) * 1997-06-09 1998-12-30 Wolf-Georg Forssmann Lus-1 human protein, its production and use
AU765600B2 (en) * 1998-07-09 2003-09-25 Merck Serono Sa Compound B as angiogenic agent in combination with human growth factors
US6962700B1 (en) * 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
ES2359408T3 (en) * 2003-04-16 2011-05-23 Merck Serono Sa Using SLURP-1 to treat diseases related to dysfunction of acetylcholine receptors diseases.
US7343581B2 (en) * 2005-06-27 2008-03-11 Tela Innovations, Inc. Methods for creating primitive constructed standard cells
US7590968B1 (en) 2006-03-01 2009-09-15 Tela Innovations, Inc. Methods for risk-informed chip layout generation
US7943967B2 (en) 2006-03-09 2011-05-17 Tela Innovations, Inc. Semiconductor device and associated layouts including diffusion contact placement restriction based on relation to linear conductive segments
US8658542B2 (en) 2006-03-09 2014-02-25 Tela Innovations, Inc. Coarse grid design methods and structures
US8245180B2 (en) 2006-03-09 2012-08-14 Tela Innovations, Inc. Methods for defining and using co-optimized nanopatterns for integrated circuit design and apparatus implementing same
US9230910B2 (en) 2006-03-09 2016-01-05 Tela Innovations, Inc. Oversized contacts and vias in layout defined by linearly constrained topology
US8839175B2 (en) 2006-03-09 2014-09-16 Tela Innovations, Inc. Scalable meta-data objects
US7932545B2 (en) 2006-03-09 2011-04-26 Tela Innovations, Inc. Semiconductor device and associated layouts including gate electrode level region having arrangement of six linear conductive segments with side-to-side spacing less than 360 nanometers
US9009641B2 (en) 2006-03-09 2015-04-14 Tela Innovations, Inc. Circuits with linear finfet structures
US8247846B2 (en) 2006-03-09 2012-08-21 Tela Innovations, Inc. Oversized contacts and vias in semiconductor chip defined by linearly constrained topology
US8225239B2 (en) 2006-03-09 2012-07-17 Tela Innovations, Inc. Methods for defining and utilizing sub-resolution features in linear topology
US9035359B2 (en) 2006-03-09 2015-05-19 Tela Innovations, Inc. Semiconductor chip including region including linear-shaped conductive structures forming gate electrodes and having electrical connection areas arranged relative to inner region between transistors of different types and associated methods
US7446352B2 (en) 2006-03-09 2008-11-04 Tela Innovations, Inc. Dynamic array architecture
US8653857B2 (en) 2006-03-09 2014-02-18 Tela Innovations, Inc. Circuitry and layouts for XOR and XNOR logic
US8448102B2 (en) 2006-03-09 2013-05-21 Tela Innovations, Inc. Optimizing layout of irregular structures in regular layout context
US8225261B2 (en) 2006-03-09 2012-07-17 Tela Innovations, Inc. Methods for defining contact grid in dynamic array architecture
US7586800B1 (en) 2006-08-08 2009-09-08 Tela Innovations, Inc. Memory timing apparatus and associated methods
US8286107B2 (en) 2007-02-20 2012-10-09 Tela Innovations, Inc. Methods and systems for process compensation technique acceleration
US7979829B2 (en) * 2007-02-20 2011-07-12 Tela Innovations, Inc. Integrated circuit cell library with cell-level process compensation technique (PCT) application and associated methods
US8667443B2 (en) 2007-03-05 2014-03-04 Tela Innovations, Inc. Integrated circuit cell library for multiple patterning
US7908578B2 (en) * 2007-08-02 2011-03-15 Tela Innovations, Inc. Methods for designing semiconductor device with dynamic array section
KR101739709B1 (en) 2008-07-16 2017-05-24 텔라 이노베이션스, 인코포레이티드 Methods for cell phasing and placement in dynamic array architecture and implementation of the same
CN101918440B (en) * 2007-09-20 2015-04-22 联邦科学技术研究组织 Use of avian cytokines and genetic sequences encoding the avian cytokines
BRPI0818039A2 (en) * 2007-10-15 2014-10-14 Chugai Pharmaceutical Co Ltd Method for producing a capable of high-income hyperoprotein production cell.
US7763534B2 (en) 2007-10-26 2010-07-27 Tela Innovations, Inc. Methods, structures and designs for self-aligning local interconnects used in integrated circuits
US8541879B2 (en) 2007-12-13 2013-09-24 Tela Innovations, Inc. Super-self-aligned contacts and method for making the same
US8453094B2 (en) 2008-01-31 2013-05-28 Tela Innovations, Inc. Enforcement of semiconductor structure regularity for localized transistors and interconnect
US7956421B2 (en) 2008-03-13 2011-06-07 Tela Innovations, Inc. Cross-coupled transistor layouts in restricted gate level layout architecture
US7939443B2 (en) 2008-03-27 2011-05-10 Tela Innovations, Inc. Methods for multi-wire routing and apparatus implementing same
US9122832B2 (en) 2008-08-01 2015-09-01 Tela Innovations, Inc. Methods for controlling microloading variation in semiconductor wafer layout and fabrication
GB0820631D0 (en) * 2008-11-11 2008-12-17 London School Hygiene & Tropical Medicine Vectors
EP2239322A1 (en) * 2009-04-07 2010-10-13 Basf Se Use of enzymes to reduce formaldehyde from formaldehyde-containing products
US9563733B2 (en) 2009-05-06 2017-02-07 Tela Innovations, Inc. Cell circuit and layout with linear finfet structures
US8661392B2 (en) 2009-10-13 2014-02-25 Tela Innovations, Inc. Methods for cell boundary encroachment and layouts implementing the Same
US9159627B2 (en) 2010-11-12 2015-10-13 Tela Innovations, Inc. Methods for linewidth modification and apparatus implementing the same
EP2740485B1 (en) * 2012-12-07 2018-10-31 Brightpulse Holding LTD. Protein slurp-1 for use in the treatment of ocular diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359415A (en) * 1981-06-03 1982-11-16 University Of Tennessee Research Corporation Isolation of an antineoplastic protein fraction and an antineoplastic peptide fraction from human urine
US4470970A (en) * 1981-07-02 1984-09-11 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US5298604A (en) * 1992-07-27 1994-03-29 Sloane Nathan H Parital primary amino acid sequence of the antineoplastic protein (ANUP); a cytokine present in granulocytes

Also Published As

Publication number Publication date
ZA9309621B (en) 1995-06-22
IL108149A (en) 2005-05-17
FI953091A (en) 1995-06-21
KR950704486A (en) 1995-11-20
ES2193152T3 (en) 2003-11-01
IT1257184B (en) 1996-01-10
DE69332861D1 (en) 2003-05-15
EP0675956B1 (en) 2003-04-09
NO952494L (en) 1995-08-21
WO1994014959A1 (en) 1994-07-07
FI953091D0 (en)
NO315800B1 (en) 2003-10-27
JPH08509359A (en) 1996-10-08
NO952494D0 (en) 1995-06-21
FI114478B (en) 2004-10-29
DE69332861T2 (en) 2004-01-29
FI116059B1 (en)
AT236976T (en) 2003-04-15
AU5833594A (en) 1994-07-19
ITRM920919D0 (en) 1992-12-22
RU2177480C2 (en) 2001-12-27
US5908827A (en) 1999-06-01
DK0675956T3 (en) 2003-07-07
CA2151156A1 (en) 1994-07-07
JP3025014B2 (en) 2000-03-27
FI116059B (en) 2005-09-15
ITRM920919A1 (en) 1994-06-23
AU690093B2 (en) 1998-04-23
EP0675956A1 (en) 1995-10-11
PT675956E (en) 2003-07-31
FI953091A0 (en) 1995-06-21
DK675956T3 (en)
FI20040608A (en) 2004-04-29
FI114478B1 (en)

Similar Documents

Publication Publication Date Title
IL104006A (en) Azaheterocyclylmethyl-chromans their preparation and pharmaceutical compositions containing them
IL108486D0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL102383D0 (en) Methylene-oxindole derivatives,their preparation and pharmaceutical compositions containing them
IL111221D0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
IL110643A (en) Amidine derivatives their preparation and pharmaceutical compositions containing them
PH31460A (en) Pharmaceutical and cosmetics and compositions.
ZA9302527B (en) New perhydroisoindole derivatives, their preparation and pharmaceutical compositions containing them
IL102833D0 (en) Azacyclic compounds,their preparation and pharmaceutical compositions containing them
IL116002D0 (en) Substituted 3-arylidene-7-azaoxindole compounds their preparation and pharmaceutical compositions containing them
IL109570D0 (en) Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
IL89576D0 (en) Peptide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IL92208D0 (en) 3-piperidinyl-1,2-benzisoxazoles,their preparation and pharmaceutical compositions containing them
GR3034492T3 (en) Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
IL113812D0 (en) Copolymer-1, pharmaceutical compositions containing it and its use
GB8929070D0 (en) Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
IL106904A (en) Pyridylamino- ethoxybenzyl- thiazolidine-2, 4-dione derivatives, their preparation and pharmaceutical compositions containing them
HU9501662D0 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
IL95351D0 (en) 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them
IL108382D0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
IL111861A (en) Phenyl-n-substituted azabicycloalkene derivatives and pharmaceutical compositions containing them
IL101864D0 (en) Thiopyranopyrrole derivatives,their preparation and pharmaceutical compositions containing them
HUT73240A (en) Cycloalkano-indol- and -azaindol derivatives and pharmaceutical compositions containing the same
NZ264319A (en) Pyridazine-3-sulphonamide derivatives; preparation and pharmaceutical compositions
NZ265547A (en) 10,11-methano-dibenzo-suberane derivatives, preparation and pharmaceutical compositions thereof
EP0482539A3 (en) Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same

Legal Events

Date Code Title Description
KB Patents renewed
KB Patents renewed
MM9K Patent not in force due to non-payment of renewal fees